Total Payments
$1,610
2024 Payments
$106.20
Companies
14
Transactions
62
Medicare Patients
475
Medicare Billing
$46,369
Payment Breakdown by Category
Food & Beverage$1,395 (86.6%)
Education$215.00 (13.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,395 | 58 | 86.6% |
| Education | $215.00 | 4 | 13.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $467.97 | 14 | $0 (2024) |
| Novo Nordisk Inc | $297.63 | 15 | $0 (2024) |
| Olympus America Inc. | $211.54 | 7 | $0 (2021) |
| Boston Scientific Corporation | $200.40 | 9 | $0 (2023) |
| Aries Pharmaceuticals, Inc. | $99.02 | 1 | $0 (2017) |
| Janssen Biotech, Inc. | $76.00 | 1 | $0 (2023) |
| Cook Medical LLC | $64.43 | 5 | $0 (2024) |
| AbbVie Inc. | $61.27 | 3 | $0 (2021) |
| Merck Sharp & Dohme LLC | $33.04 | 2 | $0 (2024) |
| Shire North American Group Inc | $25.72 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $106.20 | 5 | Gilead Sciences, Inc. ($51.16) |
| 2023 | $222.63 | 8 | Gilead Sciences, Inc. ($80.03) |
| 2022 | $139.22 | 7 | Boston Scientific Corporation ($60.37) |
| 2021 | $204.74 | 11 | Olympus America Inc. ($41.18) |
| 2020 | $159.80 | 8 | Gilead Sciences, Inc. ($45.19) |
| 2019 | $199.08 | 7 | Olympus America Inc. ($94.92) |
| 2018 | $317.22 | 8 | Gilead Sciences, Inc. ($193.78) |
| 2017 | $261.00 | 8 | Aries Pharmaceuticals, Inc. ($99.02) |
All Payment Transactions
62 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/19/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $21.94 | General |
| 08/05/2024 | Cook Medical LLC | FUSION (Device) | Food and Beverage | Cash or cash equivalent | $15.64 | General |
| Category: Endoscopy | ||||||
| 04/16/2024 | Merck Sharp & Dohme LLC | BRIDION (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: NEUROSCIENCE | ||||||
| 02/05/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.40 | General |
| Category: Diabetes | ||||||
| 01/17/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $29.22 | General |
| 10/17/2023 | Boston Scientific Corporation | SpyGlass (Device) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: SpyGlass_ENDO | ||||||
| 09/21/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $27.13 | General |
| 07/25/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $28.15 | General |
| 06/06/2023 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: Diabetes | ||||||
| 06/05/2023 | Cook Medical LLC | FUSION (Device) | Food and Beverage | Cash or cash equivalent | $13.02 | General |
| Category: Endoscopy | ||||||
| 05/16/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: Diabetes | ||||||
| 05/01/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Education | In-kind items and services | $76.00 | General |
| Category: Immunology | ||||||
| 01/10/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $24.75 | General |
| 10/28/2022 | Cook Medical LLC | FUSION QUATTRO (Device) | Food and Beverage | Cash or cash equivalent | $13.05 | General |
| Category: Endoscopy | ||||||
| 08/08/2022 | Boston Scientific Corporation | Resolution Clip (Device) | Food and Beverage | In-kind items and services | $26.39 | General |
| Category: Resolution Clip_ENDO | ||||||
| 07/27/2022 | Boston Scientific Corporation | ORISE (Device) | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: ORISE_ENDO | ||||||
| 07/25/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $24.10 | General |
| Category: Diabetes | ||||||
| 05/16/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $23.51 | General |
| Category: Diabetes | ||||||
| 05/13/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $18.19 | General |
| 04/07/2022 | Boston Scientific Corporation | General - Hemostasis (Device) | Food and Beverage | In-kind items and services | $14.19 | General |
| Category: General - Hemostasis_ENDO | ||||||
| 12/01/2021 | Cook Medical LLC | Instinct (Device) | Food and Beverage | Cash or cash equivalent | $11.45 | General |
| Category: Endoscopy | ||||||
| 11/09/2021 | STERIS Corporation | Infinity (Device), NA | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: Gastroenterology | ||||||
| 10/18/2021 | Novo Nordisk Inc | RYBELSUS (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: Diabetes | ||||||
| 05/18/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $21.17 | General |
| Category: Diabetes | ||||||
| 04/09/2021 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $19.35 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 158 | 198 | $62,018 | $17,788 |
| 2022 | 9 | 145 | 175 | $44,734 | $13,373 |
| 2021 | 4 | 81 | 128 | $23,473 | $7,468 |
| 2020 | 4 | 91 | 137 | $24,186 | $7,740 |
Total Patients
475
Total Services
638
Medicare Billing
$46,369
Procedure Codes
25
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 39 | 42 | $16,002 | $5,053 | 31.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 22 | 41 | $9,264 | $2,962 | 32.0% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 17 | 17 | $10,183 | $2,397 | 23.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 19 | 21 | $8,652 | $1,897 | 21.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 15 | 21 | $5,949 | $1,866 | 31.4% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 15 | 17 | $6,052 | $1,825 | 30.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 14 | 21 | $4,032 | $1,267 | 31.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2023 | 17 | 18 | $1,884 | $522.40 | 27.7% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 27 | 28 | $8,540 | $2,779 | 32.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 25 | 36 | $7,524 | $2,446 | 32.5% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 11 | 12 | $7,416 | $1,836 | 24.8% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 13 | 15 | $5,700 | $1,714 | 30.1% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Facility | 2022 | 14 | 18 | $5,202 | $1,667 | 32.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 13 | 18 | $3,582 | $1,153 | 32.2% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Facility | 2022 | 15 | 17 | $3,349 | $951.18 | 28.4% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 11 | 13 | $1,508 | $493.94 | 32.8% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Facility | 2022 | 16 | 18 | $1,913 | $333.66 | 17.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 23 | 47 | $9,847 | $3,233 | 32.8% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 17 | 19 | $5,748 | $1,891 | 32.9% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Facility | 2021 | 28 | 48 | $5,092 | $1,493 | 29.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 13 | 14 | $2,786 | $850.59 | 30.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 22 | 54 | $11,447 | $3,639 | 31.8% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2020 | 26 | 28 | $8,587 | $2,773 | 32.3% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Facility | 2020 | 25 | 37 | $1,443 | $871.06 | 60.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 18 | 18 | $2,709 | $456.63 | 16.9% |
About Michael Bernstein
Michael Bernstein is a Gastroenterology healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1043221450.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Michael Bernstein has received a total of $1,610 in payments from pharmaceutical and medical device companies, with $106.20 received in 2024. These payments were reported across 62 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($1,395).
As a Medicare-enrolled provider, Bernstein has provided services to 475 Medicare beneficiaries, totaling 638 services with total Medicare billing of $46,369. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Brooklyn, NY
- Active Since 08/10/2006
- Last Updated 07/08/2007
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1043221450
Products in Payments
- Rybelsus (Drug) $102.46
- MB MMX (Drug) $99.02
- Olympus EndoTherapy Accessories (Device) $93.90
- Ozempic (Drug) $78.78
- STELARA (Biological) $76.00
- HUMIRA (Biological) $61.27
- Victoza (Drug) $56.62
- Single Use Repositionable Clip (Device) $41.18
- Tresiba (Drug) $40.95
- GENERAL - HEMOSTASIS (Device) $35.00
- Olympus Hemostasis Devices (Device) $34.29
- FUSION (Device) $28.66
- Resolution Clip (Device) $26.39
- GENERAL - BILIARY DEVICES (Device) $26.35
- GATTEX (Drug) $25.72
- Olympus Biliary Devices (Device) $24.92
- RESOLUTION CLIP (Device) $24.88
- BRIDION (Drug) $20.00
- ORISE (Device) $19.79
- XIFAXAN (Drug) $19.43
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Brooklyn
Sam Moskowitz, Md, MD
Gastroenterology — Payments: $349,162
Gastroenterology $349,162
Jianjun Li, M.d, M.D
Gastroenterology — Payments: $307,830
Gastroenterology $307,830
Dr. Nison Badalov, M.d, M.D
Gastroenterology — Payments: $237,374
Gastroenterology $237,374
Smruti Mohanty, Md, Ms, MD, MS
Gastroenterology — Payments: $219,216
Gastroenterology $219,216
Dr. Jonathan Erber, Md, MD
Gastroenterology — Payments: $208,708
Gastroenterology $208,708
Dr. Rabin Rahmani, M.d, M.D
Gastroenterology — Payments: $204,380
Gastroenterology $204,380